Skip to main content
DARE logo

Daré Bioscience, Inc. (DARE)

DARENASDAQHealthcareBiotechnology

$0.41Today:+$0.00 (+0.44%)1Y −73.10%

As of Nov 20, 2026 close

Market cap
$6.73M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.41$3.78
Volume (live)
-
Avg. volume (3M)
172.89K

Daré Bioscience (DARE) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Daré Bioscience used $9.89M of cash in operating activities and spent $385.28K on capital expenditures. That left free cash flow of −$10.27M.

Daré Bioscience Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Daré Bioscience, Inc. (DARE) - Annual data in millions USD
BreakdownTTMFY 2025FY 2024FY 2024FY 2023FY 2022FY 2021FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingSep 2026Dec 2025Mar 2025Dec 2024Dec 2023Dec 2022Mar 2022Dec 2021Dec 2020Dec 2019Mar 2019Dec 2017
Operating Activities
Net Income-10.58-13.40-4.05-4.05-30.16-30.95-38.70-38.70-27.40-14.26-16.74-11.50
Depreciation & Amortization2.172.150.040.040.040.020.030.030.040.010.000.00
Stock Based Compensation1.551.502.202.202.532.161.601.600.740.460.140.02
Change in Working Capital-10.65-0.215.815.89-10.4310.708.738.731.540.710.631.14
Change in Accounts Receivable-0.22-0.340.720.720.75-0.56-0.69-0.690.10-0.200.250.66
Change in Accounts Payable-1.04-0.26-1.93-1.931.36-0.081.081.08-0.060.610.150.75
Change in Other Working Capital-5.060.397.025.00-4.573.578.33-0.650.960.300.480.39
Other Operating Activities-0.670.081.390.79-0.84-0.02-0.42-0.42-0.16-0.235.697.81
Net Cash from Operating Activities-17.70-9.895.395.47-38.86-18.09-28.76-28.76-25.23-13.32-10.27-2.54
Investing Activities
Capital Expenditures-0.49-0.39-0.57-0.57-0.63-0.06-0.01-0.01-0.020.00-0.010.00
Acquisitions-0.000.00-0.000.000.00-0.006.14-0.519.92
Other Investing Activities-0.000.00-0.000.000.00-0.000.00-0.519.92
Net Cash from Investing Activities-0.49-0.39-0.57-0.57-0.63-0.06-0.01-0.01-0.026.14-0.529.92
Financing Activities
Debt Repayment-1.19-0.39-0.02-0.58-0.330.000.00-0.370.000.000.16
Common Stock Issued7.1620.930.450.459.351.3475.3175.8524.765.1510.110.00
Other Financing Activities--1.260.00-0.084.720.120.53-0.000.000.000.00
Net Cash from Financing Activities6.6219.280.430.3515.641.3475.8575.8525.135.1510.110.16
Summary
Effect of Forex Changes on Cash0.030.01-0.07-0.07-0.01-0.20-0.06-0.060.01-0.01-0.08-0.02
Net Change in Cash-11.549.015.195.19-23.86-17.0047.0047.00-0.11-2.03-0.757.52
Cash at Beginning of Period23.0816.0010.8110.8134.6751.674.674.674.786.817.560.04
Cash at End of Period11.8325.0116.0016.0010.8134.6751.6751.674.674.786.817.56
Free Cash Flow-18.19-10.274.824.90-39.49-18.15-28.78-28.78-25.25-13.32-10.28-2.54

Source: Company financial statements from annual and quarterly filings. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions About Daré Bioscience Cash Flow

What is Daré Bioscience's free cash flow?

Daré Bioscience had negative free cash flow of $10.27M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$9.89M minus $385.28K of capital expenditures.

How much does Daré Bioscience spend on capital expenditures?

Daré Bioscience spent $385.28K on capital expenditures in fiscal 2025, compared with $573.05K a year earlier.

Does Daré Bioscience pay dividends or buy back shares?

Daré Bioscience's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition